Milestone Reflects Deepening Customer Centricity as DNAnexus Continues to Scale its Platform for the World’s Leading Life Sciences Organizations, Accelerating Growth By Global Expansion
Today, DNAnexus, the world’s most trusted platform for omics data enablement, announced it has achieved a 90% customer satisfaction score (CSAT) — a milestone underscoring the trust that the world’s leading biopharma, diagnostic, and health system organizations place in the platform as DNAnexus continues to achieve global scale and accelerate growth.
The 90% CSAT arrives alongside the recent launch of new product innovations and solution packages engineered to accelerate AI-driven discovery and reinforces DNAnexus’s successful evolution into the omics data layer for the AI era of precision health. As customers increasingly rely on DNAnexus to transform the most complex data in healthcare into a governed, AI-ready, reusable asset, the company is positioning its platform as the connective infrastructure the industry needs to move from sequence to scientific breakthrough at industrial scale.
“Customer centricity is central to how we build and scale our technology solutions,” said Kristy Cloyd-Warwick, Ph.D., senior vice president of customer experience and professional services at DNAnexus. “When researchers are pushing the boundaries of human health and encounter friction, we’re there to clear the path. A 90% CSAT tells us we’re delivering on that promise — not just as a technology solution, but as a partner ensuring our customers can stay focused on delivering scientific breakthroughs and improving patient outcomes.”
The milestone lands amid a period of sustained, accelerating growth — the latest chapter in nearly two decades of expansion -— as DNAnexus continues to scale its footprint across biopharma R&D, diagnostics, health systems, and biobanks. This reinforces the company’s trajectory as demand accelerates for platforms that can contextualize, orchestrate, and federate raw multimodal data at scale, while operationalizing AI across critical workflows with regulatory-grade readiness. As AI becomes essential to how life sciences and healthcare organizations discover, validate, and deploy modern science, DNAnexus is positioning itself as the platform those efforts increasingly run on.
Powered by the largest repository of genomic and omics data in the world, DNAnexus is where the largest globally connected community of scientists synthesizes biological intelligence at unmatched industrial scale and global reach. In its seventeen years of operation, DNAnexus has processed more than 135 petabytes of genomic and multiomic data — the scale and quality of molecular data required to train and validate AI models for precision health. Today, that infrastructure supports more than 130 enterprise customers and 64,000 researchers across 54 countries as they harness AI to move from data to discovery faster.
That scale has produced rare data gravity, hard-won regulatory trust, and production-grade infrastructure. Together, these position DNAnexus as the industry’s most trusted platform for omics — a company operating at the apex of scientific and computational innovation — from FDA regulatory submissions to CAP/CLIA clinical production environments.
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!